Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
Kahn Brothers Group Portfolio 13F
Kahn Brothers Group Holdings Activity
- Portfolio value:
- $592.07M≈ (+$12M≈)
- Previous value:
- $580.19M≈
- # of changes:
- 33
- New positions:
- 0
- Reported for:
- 31 Mar 2015 (Q1)
- Latest filing date:
- 06 May 2015
Kahn Brothers Group has disclosed a total of 33 changes to the portfolio in the (2015 Q1) SEC report(s): increased the number of shares of 4, decreased the number of shares of 27 and completely sold out 2 position(s).
What stocks did Kahn Brothers Group buy in 2015 Q1?
In the 2015 Q1 report(s) the following changes have been made to the top investments: (PFE) Pfizer Inc (reduced shares -3.83%), (MRK) Merck & Company Inc (reduced shares -2.18%), (C) Citigroup Inc (reduced shares -4.99%), (NYT) New York Times Company (reduced shares -3.12%) and (FLG) Flagstar Financial, Inc (reduced shares -4.14%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.